Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05674240 · ClinicalTrials.gov registry record
Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
A clinical trial of Chronic Pain and Neuropathic Pain, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05674240: Active study of Chronic Pain and Neuropathic Pain, sponsored by Wake Forest University Health Sciences.
NCT05674240 is a study of Chronic Pain and Neuropathic Pain that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 30 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05674240, a study of Chronic Pain and Neuropathic Pain, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This Registry study will prospectively evaluate the differences in treatment outcomes in terms of pain intensity, pain interference, concomitant medication use, health-related quality of life, opioid adverse effects, and healthcare utilization between targeted drug delivery and conservative medication management only groups.
Primary Outcome
Change from baseline to Month 3 post treatment plan implementation in average pain as measured through Numerical Rating Scale (0-10 where higher scores mean worse outcome)
Conditions Studied
Interventions
- DEVICE Intrathecal Targeted Drug Delivery
- COMBINATION_PRODUCT Conservative medical management
Study Locations (1)
Wisconsin
- Advocate Aurora Health - Oshkosh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-12-06 |
| Est. Completion | 2026-03-20 |
What the registry record for NCT05674240 still lists
NCT05674240 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Intrathecal Targeted Drug Delivery is the first listed.
NCT05674240 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05674240 about?
NCT05674240 is a clinical study titled "Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain". This Registry study will prospectively evaluate the differences in treatment outcomes in terms of pain intensity, pain interference, concomitant medication use, health-related quality of life, opioid adverse effects, and healthcare utilization between targeted drug delivery and conservative medicati...
What is the current status of trial NCT05674240?
This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2022-12-06. Estimated completion is 2026-03-20.
What conditions does trial NCT05674240 study?
This clinical trial studies the following conditions: Chronic Pain, Neuropathic Pain, Cancer Pain, Cancer Associated Pain.
What interventions are being tested in trial NCT05674240?
The interventions under investigation include: Intrathecal Targeted Drug Delivery (DEVICE), Conservative medical management (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05674240?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05674240 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05674240's enrollment target sits among peer trials
30 244th of 301 higher than 48 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI